Evaluation of diffusing capacity in patients with a restrictive lung disease

Chest

Volumn 117, Issue 3, 2000, Pages 752-757

  Stam, Henk ^a,b   Splinter, Ted A W ^b   Versprille, Adrian ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Alveolar volume; Bleomycin; Chemotherapy; Diffusing capacity; Restrictive lung disease

Indexed keywords

ADULT; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GAS EXCHANGE; HUMAN; LUNG DIFFUSION; LUNG TOXICITY; LUNG VOLUME; MALE; PRIORITY JOURNAL; SMOKING; TOTAL LUNG CAPACITY;

EID: 0034018076     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.3.752     Document Type: Article

References (22)

1. 1 Stam H, Hrachovina V, Stijnen T, et al. Diffusing capacity dependent on lung volume and age in normal subjects. J Appl Physiol 1994; 76:2356-2363
2. 2 Stam H, van der Beek A, Grünberg K, et al. Pulmonary diffusing capacity at reduced alveolar volumes in children. Pediatr Pulmonol 1996; 21:84-89
3. 3 Billiet L. De bepaling van de pulmonaire diffusie capaciteit (thesis). Leuven, Belgium; University of Leuven, 1965
4. 4 Cadigan JB, Marks A, Ellicott MF, et al. An analysis of factors affecting the measurement of pulmonary diffusing capacity by the single breath method. J Clin Invest 1961; 40:1495-1514
5. SB-3EQ with lung volume in normal subjects. J Appl Physiol 1992; 73:434-439
6. 6 Gurtner GH, Fowler WS. Interrelationships of factors affecting pulmonary diffusing capacity. J Appl Physiol 1971; 30: 619-624
7. CO). Thorax 1978; 33:728-733
8. 8 Marks A, Cugell DW, Cadigan JB, et al. Clinical determination of the diffusing capacity of the lungs. Am J Med 1957; 22:51-73
9. 9 McGrath MW, Thomson ML. The effect of age body size and lung volume change on alveolar-capillary permeability and diffusing capacity in man. J Physiol Lond 1959; 146:572-582
10. A) for early detection of alveolar capillary defects. Lung 1979; 157:23-29
11. 11 Stam H, Versprille A, Bogaard JM. The components of the carbon monoxide diffusing capacity in man dependent on alveolar volume. Bull Eur Physiopathol Respir 1983; 19: 17-22
12. 12 Stam H, Kreuzer FJA, Versprille A. Effect of lung volume and positional changes on pulmonary diffusing capacity and its components. J Appl Physiol 1991; 71:1477-1488
13. 13 Quanjer PhH. Standardized lung function testing. Bull Eur Physiopathol Respir 1983; 19(Suppl5):39-44
14. 14 Blum R, Carter SK, Agre K. A clinical review of bleomycin: a new antineoplastic agent. Cancer 1973; 31:903-914
15. 15 Ginsberg SJ, Comis RL. The pulmonary toxicity of antineoplastic agents. Semin Oncol 1982; 9:34-51
16. 16 Pascual RS, Mosher MD, Sikaud RS, et al. Effects of bleomycin on pulmonary function in man. Am Rev Respir Dis 1973; 108:211-217
17. 17 Comis RL, Kuppinger MS, Ginsbert SJ, et al. Role of single-breath carbon monoxide diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumour patients. Cancer Res 1979; 39:5076-5080
18. 18 Perez-Guerra F, Harkleroad LE, Walsh RE, et al. Acute bleomycin lung. Am Rev Respir Dis 1972; 106:909-913
19. 19 Lebecque P, Mwepu A, Veriter C, et al. Hysteresis of the alveolar capillary membrane in normal subjects. J Appl Physiol 1986; 60:1442-1445
20. 20 Ferris BG. Epidemiology standardization project. Am Rev Respir Dis 1978; 118(suppl):62-72
21. 21 Cotes JE. Lung function: assessment and application in medicine. 4th ed. Oxford, UK: Blackwell, 1979
22. 22 Roberts CM, McRae KD, Seed WA. Multiple breath and single breath helium dilution lung volumes as a test of obstruction. Eur Respir J 1990; 3:515-520